Check out our most popular compounded medications! Get Started
EGCG 200 mg/Levocarnitine 10 mg Slow Release Capsules are a compounded formulation designed to treat conditions such as obesity, diabetes, cardiovascular disease, Alzheimer's disease, and hyperlipidemia. These capsules utilize Methocel E4M, a controlled-release polymer, to gradually release the active ingredients over an extended period. This slow release mechanism ensures sustained therapeutic effects, reduced dosing frequency, and improved patient compliance, particularly for medications requiring a controlled and prolonged release profile.
Licensed to fill prescriptions for patients in RI, MA, CT, NJ, NH, FL, ME and PA. New York patients are served on a limited basis while nonresident registration is pending.
This formulation of EGCG 200 mg/Levocarnitine 10 mg Slow Release Capsules is a potent blend of two active ingredients, encapsulated using Methocel E4M, a controlled-release polymer. This advanced formulation is designed to gradually release the active ingredients over an extended period, providing sustained therapeutic effects, reducing the need for frequent dosing, and enhancing patient compliance, particularly for medications requiring a controlled and prolonged release profile.
EGCG, a powerful antioxidant, has demonstrated anti-inflammatory and anti-obesity effects. It has been shown to reduce body weight and fat mass, making it a potential treatment for obesity. In the context of diabetes, EGCG can reduce insulin resistance and improve glucose tolerance. It also has potential benefits for cardiovascular disease, as it can reduce inflammation and improve endothelial function. Furthermore, EGCG has shown promise in Alzheimer's disease treatment by reducing oxidative stress and improving cognitive function. For hyperlipidemia, EGCG can help reduce triglyceride levels.
Levocarnitine, an amino acid, plays a crucial role in transporting fatty acids into the mitochondria for energy production. It can increase energy expenditure, which is beneficial for obesity treatment. In diabetes management, levocarnitine can help reduce blood glucose levels. It can also contribute to cardiovascular health by reducing cholesterol levels. In the context of Alzheimer's disease, levocarnitine can help reduce amyloid-beta levels. For hyperlipidemia, levocarnitine can assist in reducing LDL cholesterol levels.
Together, the EGCG 200 mg/Levocarnitine 10 mg Slow Release Capsules formulation offers a comprehensive approach to managing a variety of disease states. If you have any questions about this formulation, please feel free to reach out to us at Bayview Pharmacy.
This compounded formulation of EGCG 200 mg/Levocarnitine 10 mg Slow Release Capsules is designed to offer sustained therapeutic effects over an extended period of time. The capsules are formulated with Methocel E4M, a type of controlled-release polymer, which allows for a gradual release of the encapsulated medication or active ingredient. This slow release mechanism can lead to reduced dosing frequency and improved patient compliance, particularly beneficial for medications requiring a controlled and prolonged release profile.
EGCG, a polyphenol found in green tea, is known for its anti-inflammatory, antioxidant, and anti-obesity properties. It has been shown to potentially help reduce body weight, waist circumference, and body fat mass in patients with obesity. Additionally, EGCG may help reduce fasting blood glucose levels and improve insulin sensitivity in patients with diabetes. It may also contribute to the reduction of total cholesterol, LDL cholesterol, and triglycerides in patients with hyperlipidemia.
Levocarnitine, an amino acid that aids in energy production within the body, is another key component of this formulation. It may help reduce fatigue and improve exercise capacity in patients with cardiovascular disease. Furthermore, Levocarnitine may help improve cognitive function in patients with Alzheimer's disease.
Please consult with a healthcare professional for personalized medical advice.
This EGCG 200 mg/Levocarnitine 10 mg Slow Release Capsule formulation is a meticulously designed treatment option for a range of health conditions including obesity, diabetes, cardiovascular disease, Alzheimer's disease, and hyperlipidemia. The capsules contain EGCG, or epigallocatechin gallate, a potent polyphenol found in green tea, known for its antioxidant, anti-inflammatory, and anti-obesity properties. Studies have demonstrated EGCG's ability to reduce body weight, body fat, and waist circumference in obese individuals.
Levocarnitine, the other active ingredient in this formulation, is an amino acid that aids the body in converting fat into energy. It has been shown to improve insulin sensitivity and reduce blood sugar levels in individuals with diabetes. Additionally, it has been found to lower cholesterol levels, thereby promoting cardiovascular health. Levocarnitine has also been associated with improved cognitive function in Alzheimer's patients and reduced triglyceride levels in those with hyperlipidemia.
The unique feature of this formulation is its slow-release design. The capsules are formulated with Methocel E4M, a controlled-release polymer, which ensures the gradual release of the encapsulated medication over an extended period. This allows for sustained therapeutic effects, reduced dosing frequency, and improved patient compliance, particularly beneficial for medications requiring a controlled and prolonged release profile.
The EGCG 200 mg/Levocarnitine 10 mg Slow Release Capsules are easy to take and can be consumed with or without food, offering flexibility and convenience for the patient. If you have any queries about this formulation or its potential benefits in treating obesity, diabetes, cardiovascular disease, Alzheimer's disease, or hyperlipidemia, please do not hesitate to contact us. We are committed to helping you find the most suitable treatment option tailored to your individual health needs.
This is a compounded formulation of two active ingredients, EGCG and Levocarnitine, encapsulated in a controlled-release polymer called Methocel E4M. This design allows for the gradual release of the medication over an extended period of time.
Methocel E4M is a type of controlled-release polymer. It is designed to gradually release the encapsulated medication or active ingredient over an extended period of time, offering sustained therapeutic effects and improved patient compliance.
Slow-release capsules offer several benefits. They provide sustained therapeutic effects, reduce the frequency of dosing, and improve patient compliance, especially for medications requiring a controlled and prolonged release profile.
EGCG 200 mg/Levocarnitine 10 mg refers to the amount of each active ingredient in the capsule. Each capsule contains 200 mg of EGCG and 10 mg of Levocarnitine.
The frequency of dosing will depend on your doctor's prescription. However, due to the slow-release nature of the capsule, the frequency of dosing is typically reduced compared to regular capsules.
If you miss a dose, take it as soon as you remember. If it is near the time of the next dose, skip the missed dose and resume your usual dosing schedule. Do not double the dose to catch up.
No, the capsule should not be broken or chewed. Doing so can release all of the drug at once, increasing the risk of side effects. The capsule should be swallowed whole.
As with any medication, side effects can occur. If you experience any unusual symptoms or side effects, you should contact your healthcare provider immediately.
Before starting any new medication, you should always inform your healthcare provider about any other drugs you are currently taking to avoid potential drug interactions.
Store the capsules at room temperature, away from light and moisture. Do not store in the bathroom. Keep all medications away from children and pets.
This formulation is compounded by Bayview Pharmacy on a prescriber's order for an individual patient. It is not an FDA-approved drug product, and the FDA has not evaluated it for safety, effectiveness, or manufacturing quality.
A valid prescription is required. Availability depends on Bayview's licensure in your state. This page is general information, not medical advice. Discuss your situation with a licensed healthcare provider.
Search by NCPDP 4106882, or by name and ZIP: Bayview Pharmacy, Warwick, RI 02886. Select it as the destination pharmacy and save it as a favorite. Click any value to copy it.
Compounded preparations have no NDC, so this formula will not appear in your EHR's drug search. Use your system's compound, non-formulary, or free-text prescription entry and name the preparation exactly as written in step 3. If your EHR forces you to pick a listed drug, pick the closest entry for the active ingredient and put the full formula in the prescription body (the Sig or directions field), not in Notes to Pharmacy.
Compounded preparations have no NDC and will not appear in your drug search. For EPCS to validate, select a drug entry your EHR recognizes as controlled, usually the bulk powder entry for the active ingredient (for example Ketamine (bulk) powder, not a branded product), then put the full formula from step 3 in the prescription body. A free-text entry that does not validate as controlled will be rejected by your EPCS module.
Quantity and directions are starting points for this dose form, not treatment recommendations. Dosing remains the prescriber's responsibility.
Transmit from your EHR. For this non-controlled preparation we also accept fax to (401) 284-4506 and phoned orders at (401) 284-4505. Order forms are on the formulation pages and in the prescriber portal.
Transmit with two-factor authentication through your EPCS-enabled EHR. No order form is offered for this preparation; e-prescribing guides for our controlled preparations are on the formulation pages.
Licensed to dispense in RI, MA, CT, NJ, NH, FL, ME, and PA; New York is served on a limited basis while nonresident registration is pending. Compounded preparations are not FDA-approved. A valid prescription is required. Full guide, including steps by EHR: How to e-prescribe to Bayview. Questions about this formula: call (401) 284-4505.
Take 1 capsule by mouth
